8-KItem 5.02 · Officer/Director ChangeItem 9.01 · Financial Statements
DEXCOM INC (DXCM)

DexCom filed an 8‑K adding an Offer Letter effective Jan 1, 2026 with Jacob S.

Filed with the SEC on · Summarized by InvestorsBot

DexCom filed an 8‑K adding an Offer Letter effective Jan 1, 2026 with Jacob S. Leach (Ex.10.1 — management/compensatory arrangement). Filing does not disclose compensation amounts. $DXCM 📄 #8K #ExecHire #Compensation

8‑K dated Dec 22, 2025, signed by CFO Jereme M. Sylvain; includes Inline XBRL cover page (Ex.104). Investors should watch for follow‑on disclosures detailing Leach’s role and pay. $DXCM 🖊️ #SECfilings #CorpGov

Read the original filing on SEC EDGAR

Get summaries like this in your inbox every morning

Pick up to 20 companies — we read their SEC filings overnight and send you the plain-English version. Free.

Subscribe free

More from DEXCOM INC

Dexcom Executive Chair Kevin Sayer sells $2.0M in stock

Form 4 · Insider Trade · July 21, 2026

DexCom files 8-K (Item 9.01): Exhibit 10.1 — Letter Agreement dated Feb 27, 2026 between DexCom, Inc.

8-K · March 2, 2026

Kevin R.

8-K · March 2, 2026

Dexcom filed Form 8‑K on Feb 26, 2026: Item 9.01 lists Exhibit 99.1 (press release dated Feb 26, 2026) and…

8-K · February 26, 2026

Dexcom ($DXCM) announced on Feb 26, 2026 the appointment of Mr.

8-K · February 26, 2026

Dexcom Board expands to 12; appointed Albert F.

8-K · February 26, 2026